Current State of Target Treatment in BRAF Mutated Melanoma
Enrica T. Tanda(Ospedale Policlinico San Martino), Francesco Spagnolo(Martin University), Paola Ghiorzo(Ospedale Policlinico San Martino), Virginia Andreotti(University of Genoa), Andrea Boutros(The University of Sydney), William Bruno(Ospedale Policlinico San Martino), Irene Vanni(Ospedale Policlinico San Martino)
Cited by 96
Related Papers
Genome-wide association study identifies three new melanoma susceptibility loci
|Nature Genetics|2011|250
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
|Nature Genetics|2015|245
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
|Nature Genetics|2020|238
Common sequence variants on 20q11.22 confer melanoma susceptibility
|Nature Genetics|2008|226
The treatment of advanced melanoma: Current approaches and new challenges
|Critical Reviews in Oncology/Hematology|2024|140